Synkrino Biotherapeutics
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- Headquarters
- Oakland, California
- Employees
- 1–10
- Website
- synkrino.bio
- Last Round
- Venture RoundJan 2018
- Rounds
- 1
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
Summary
Synkrino Biotherapeutics is a Biotech company based in Oakland, United States. Its most recent funding was a Venture Round in Jan 2018. Investors include Y Combinator.
Funding History
2018 (est.)
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synkrino-development-company"><img src="https://indexed.vc/api/badge/company/synkrino-development-company" alt="Synkrino Biotherapeutics on Indexed.vc" width="260" height="76" /></a>